Krina Patel, MD, Highlights CARTITUDE-4 Data in MM

Krina Patel, MD, MSc, of the University of Texas MD Anderson Cancer Center, discusses progression-free survival and measurable residual negativity results from the CARTITUDE-4 trial of ciltacabtagene autoleucel versus standard of care in lenalidomide-refractory multiple myeloma presented at the 66th American Society of Hematology Annual Meeting & Exposition.